Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells
Authors:
- 22 April 2023
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (6) , 1523-1535
Abstract
Chimeric antigen receptor T cell therapy (CAR-T) is a novel treatment that has produced unprecedented clinical effects in patients with hematological malignancies. Acute adverse events often occur following adoptive immunotherapy. Therefore, a suicide gene is helpful, which is a genetically encoded mechanism that allows selective destruction of adoptively transferred T cells in the face of unacceptable toxicity. RQR8 is a gene that integrates CD34 and CD20 epitopes. In our study, we incorporated the suicide gene RQR8 into CAR-T cells, so it enabled rituximab to eliminate vector/transgene-expressing T cells via antibody-dependent cell-mediated cytotoxicity and complement dependent cytotoxicity. In this work, we explored the functionality of RQR8 CAR-T cells in vitro and in vivo. We believe that RQR8 as a safety switch will make CAR-T cell therapy safer and less costly.Keywords
Funding Information
- The General Project of National Natural Science Foundation of China (81970180)
- the Key Science and Technology Bureau (20YFZCSY00800)
- Tianjin Key Medical Discipline (Specialty) Construction Project
This publication has 34 references indexed in Scilit:
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialThe Lancet, 2015
- The inducible caspase-9 suicide gene system as a “safety switch†to limit on-target, off-tumor toxicities of chimeric antigen receptor T cellsFrontiers in Pharmacology, 2014
- Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaNew England Journal of Medicine, 2014
- A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapyBlood, 2014
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaScience Translational Medicine, 2014
- Comparison of Different Suicide-Gene Strategies for the Safety Improvement of Genetically Manipulated T CellsHuman Gene Therapy Methods, 2012
- Inducible Apoptosis as a Safety Switch for Adoptive Cell TherapyNew England Journal of Medicine, 2011
- Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyBlood, 2011
- The epitope recognized by rituximabBlood, 2006
- An inducible caspase 9 safety switch for T-cell therapyBlood, 2005